ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Clinical Practice Session

Contrast-Associated AKI: Does It Exist and What Should We Tell Patients?

November 09, 2019 | 10:30 AM - 12:30 PM

Location: Ballroom B, Walter E. Washington Convention Center

Session Description

Patients with underlying kidney diseases are often given conflicting information about nephrotoxic contrast risk when they require contrast-based imaging. This is based on recent data, primarily from the radiology literature, that suggest contrast-associated AKI is overestimated or nonexistent. However, other data suggest that contrast-associated AKI is a real clinical problem, particularly in patients with underlying risk factors. Potential mechanisms of contrast-associated AKI and interventions to prevent injury are reviewed.

Learning Objective(s)

  • Discuss the controversy concerning the role of contrast in causing AKI
  • Summarize new data on potential mechanisms of contrast-associated AKI
  • Describe the effective interventions to reduce contrast-associated kidney diseases

Learning Pathway(s)

  • Acute Kidney Injury
  • Cell and Transport Physiology

Moderators

  • Kevin W. Finkel, MD, FASN
  • Amy W. Williams, MD

Presentations

  • Contrast Does Not Cause AKI
    10:30 AM - 11:00 AM
    Jennifer McDonald, PhD 
  • Contrast Is Associated with AKI
    11:00 AM - 11:30 AM
    Glenn Matthew Chertow, MD, MPH, FASN
  • Interventions to Prevent Contrast-Associated AKI
    11:30 AM - 12:00 PM
    Steven D. Weisbord, MD, FASN
  • Potential Mechanisms Underlying Contrast-Associated AKI
    12:00 PM - 12:30 PM
    Daniel A. Muruve, MD